share_log
Reuters ·  Apr 29 06:39
X4 Pharmaceuticals Shares Rise 12.5% Premarket After US FDA Approves Co's Immunodeficiency Drug
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment